News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioCapital
MedImmune, Inc. To Present At The 2006 UBS Warburg Global Life Sciences Conference
September 19, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
GAITHERSBURG, Md., Sept. 18 /PRNewswire-FirstCall/ -- MedImmune, Inc. (Nasdaq: MEDI - News) announced today that it will present at the 2006 UBS Global Life Sciences Conference on Monday, September 25, 2006, at 11:30 a.m. eastern time.
Twitter
LinkedIn
Facebook
Email
Print
Events
MORE ON THIS TOPIC
Podcast
AbbVie keeps M&A rolling, FDA’s reversal train chugs along, BIO 2026 dispatch, more
June 24, 2026
·
1 min read
·
Jef Akst
Antibody-drug conjugate
Can ADCs be kinder and gentler? Join
BioSpace
at BIO to find out
June 23, 2026
·
3 min read
·
Annalee Armstrong
Editorial
BIO 2026: Cell and gene therapy sector must break the mold to thrive
June 22, 2026
·
4 min read
·
Jef Akst
Podcast
Lilly tees off with Novo at ADA, GSK’s $10.6B deal, FDA reform continues in Makary’s absence
June 10, 2026
·
2 min read
·
Jef Akst
